Tolerogenic dendritic cells: Key regulators of peripheral tolerance in health and disease

International Archives of Allergy and Immunology

Volumn 161, Issue 4, 2013, Pages 293-303

  Saei, Azad ^a   Hadjati, Jamshid ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dendritic cells; Immunotherapy; Maturation; Peripheral tolerance; Regulatory T cells; Tolerance

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 35; TRANSFORMING GROWTH FACTOR BETA; ALPHA INTERFERON; ANISPERIMUS; ARGINASE; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN; COLECALCIFEROL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 5; LYMPHOCYTE ACTIVATION GENE 3; MONOCLONAL ANTIBODY CD3; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; SCATTER FACTOR; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; UVOMORULIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VITAMIN D;

BACTEROIDES; BACTEROIDES THETAIOTAOMICRON; DENDRITIC CELL; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; INFLAMMATORY DISEASE; LACTOBACILLUS CASEI; MICROENVIRONMENT; MICROFLORA; PRIORITY JOURNAL; REVIEW; STEADY STATE; TUMOR CELL; ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; MEDIATOR; MIXED LYMPHOCYTE REACTION; NONHUMAN; TOLEROGENIC DENDRITIC CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CELLULAR MICROENVIRONMENT; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; NEOPLASMS; PERIPHERAL TOLERANCE;

EID: 84877846270     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350328     Document Type: Review

References (81)

1. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137: 1142-1162
2. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392: 245-252
3. Steinman RM: Dendritic cells: Understanding immunogenicity. Eur J Immunol 2007; 37(suppl 1):S53-S60
4. Granucci F, Zanoni I, Feau S, Capuano G, Ricciardi- Castagnoli P: The regulatory role of dendritic cells in the immune response. Int Arch Allergy Immunol 2004; 134: 179-185
5. Palucka K, Banchereau J: Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12: 265-277
6. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, et al: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863-869
7. Liu YC, Simmons DP, Li X, Abbott DW, Boom WH, Harding CV: TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9. J Immunol 2012; 188: 1019-1026
8. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196: 1627-1638
9. Legge KL, Gregg RK, Maldonado-Lopez R, Li L, Caprio JC, Moser M, et al: On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med 2002; 196: 217-227
10. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, et al: Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206: 549-559
11. Dhodapkar MV, Steinman RM: Antigenbearing immature dendritic cells induce peptide- specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100: 174-177
12. Schildknecht A, Brauer S, Brenner C, Lahl K, Schild H, Sparwasser T, et al: FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steadystate dendritic cells. Proc Natl Acad Sci USA 2010; 107: 199-203
13. Rouard H, Marquet J, Leon A, Maison P, Haioun C, Copie-Bergman C, et al: IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells. J Immunother 2002; 25: 324-333
14. Pulendran B, Tang H, Manicassamy S: Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol 2010; 11: 647-655
15. Lutz MB: Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol 2012; 3: 123
16. Sporri R, Reis e Sousa C: Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005; 6: 163-170
17. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, et al: Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002; 195: 15-21
18. Reis e Sousa C: Dendritic cells in a mature age. Nat Rev Immunol 2006; 6: 476-483
19. Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, Faridar A, et al: Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res 2011; 51: 153-160
20. Munn DH: Tolerogenic antigen-presenting cells. Ann NY Acad Sci 2002; 961: 343-345
21. Pletinckx K, Dohler A, Pavlovic V, Lutz MB: Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol 2011; 2: 39
22. Li Q, Guo Z, Xu X, Xia S, Cao X: Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation. Eur J Immunol 2008; 38: 2751- 2761
23. Luckey U, Schmidt T, Pfender N, Romer M, Lorenz N, Martin SF, et al: Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance. J Allergy Clin Immunol 2012; 130: 781.e711-797.e711
24. Gomez de Aguero M, Vocanson M, Hacini- Rachinel F, Taillardet M, Sparwasser T, Kissenpfennig A, et al: Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest 2012; 122: 1700-1711
25. You Q, Cheng L, Kedl RM, Ju C: Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008; 48: 978- 990
26. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, et al: Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 2009; 182: 1901-1911
27. Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, Kalinski P: Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 2008; 68: 5972-5978
28. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, Butcher EC: CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 2008; 9: 1253-1260
29. Fabricius D, Neubauer M, Mandel B, Schutz C, Viardot A, Vollmer A, et al: Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J Immunol 2010; 184: 677-684
30. Maldonado RA, von Andrian UH: How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 2010; 108: 111-165
31. Natarajan S, Thomson AW: Tolerogenic dendritic cells and myeloid-derived suppressor cells: Potential for regulation and therapy of liver auto- and alloimmunity. Immunobiology 2010; 215: 698-703
32. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174
33. Peche H, Heslan M, Usal C, Amigorena S, Cuturi MC: Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 2003; 76: 1503-1510
34. Karlsson M, Lundin S, Dahlgren U, Kahu H, Pettersson I, Telemo E: 'Tolerosomes' are produced by intestinal epithelial cells. Eur J Immunol 2001; 31: 2892-2900
35. Fu C, Jiang A: Generation of tolerogenic dendritic cells via the E-cadherin/beta-cateninsignaling pathway. Immunol Res 2010; 46: 72- 78
36. Van den Bossche J, Malissen B, Mantovani A, De Baetselier P, Van Ginderachter JA: Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. Blood 2012; 119: 1623-1633
37. Riedl E, Stockl J, Majdic O, Scheinecker C, Knapp W, Strobl H: Ligation of E-cadherin on in vitro-generated immature Langerhanstype dendritic cells inhibits their maturation. Blood 2000; 96: 4276-4284
38. van den Broek M: Dendritic cells break bonds to tolerize. Immunity 2007; 27: 544-546
39. Tezuka H, Ohteki T: Regulation of intestinal homeostasis by dendritic cells. Immunol Rev 2010; 234: 247-258
40. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, et al: Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 2006; 116: 916-928
41. Kushwah R, Oliver JR, Zhang J, Siminovitch KA, Hu J: Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J Immunol 2009; 183: 7104-7118
42. Griffith TS, Ferguson TA: Cell death in the maintenance and abrogation of tolerance: The five Ws of dying cells. Immunity 2011; 35: 456-466
43. Ferguson TA, Griffith TS: A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev 2006; 213: 228-238
44. Boisgerault F, Liu Y, Anosova N, Dana R, Benichou G: Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation 2009; 87: 16-23
45. Wallet MA, Sen P, Tisch R: Immunoregulation of dendritic cells. Clin Med Res 2005; 3: 166-175
46. Saas P, Angelot F, Bardiaux L, Seilles E, Garnache- Ottou F, Perruche S: Phosphatidylserine- expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect? Transfus Clin Biol 2012; 19: 90-97
47. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, et al: Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150
48. Kornete M, Piccirillo CA: Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance. Front Immunol 2012; 3: 165
49. Bimczok D, Rau H, Wundrack N, Naumann M, Rothkotter HJ, McCullough K, et al: Cholera toxin promotes the generation of semimature porcine monocyte-derived dendritic cells that are unable to stimulate T cells. Vet Res 2007; 38: 597-612
50. Hurwitz AA, Watkins SK: Immune suppression in the tumor microenvironment: A role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother 2012; 61: 289-293
51. Steinman RM, Witmer MD: Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 1978; 75: 5132-5136
52. Scott CL, Aumeunier AM, Mowat AM: Intestinal CD103+ dendritic cells: Master regulators of tolerance? Trends Immunol 2011; 32: 412-419
53. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, et al: Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007; 449: 361-365
54. Yamazaki S, Steinman RM: Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J Dermatol Sci 2009; 54: 69-75
55. Belkaid Y, Oldenhove G: Tuning microenvironments: Induction of regulatory T cells by dendritic cells. Immunity 2008; 29: 362-371
56. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, et al: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204: 1757-1764
57. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000; 164: 3596-3599
58. Mellor AL, Munn DH: IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774
59. Giannoukakis N, Trucco M: A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2012; 19: 279-287
60. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M: Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011; 34: 2026-2032
61. Harry RA, Anderson AE, Isaacs JD, Hilkens CMU: Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 2010; 69: 2042-2050
62. Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo E, Contemi AM, et al: Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004; 34: 1291-1302
63. Pacciani V, Gregori S, Chini L, Corrente S, Chianca M, Moschese V, et al: Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J Allergy Clin Immunol 2010; 125: 727-736
64. Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R, et al: High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003; 11: 245-258
65. Penna G, Amuchastegui S, Laverny G, Adorini L: Vitamin D receptor agonists in the treatment of autoimmune diseases: Selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res 2007; 22(suppl 2): V69-V73
66. Hackstein H, Thomson AW: Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24-34
67. Li M, Zhang X, Zheng X, Lian D, Zhang ZX, Ge W, et al: Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 2007; 178: 5480-5487
68. Fu H, Song S, Liu F, Ni Z, Tang Y, Shen X, et al: Dendritic cells transduced with SOCS1
69. Gene exhibit regulatory DC properties and prolong allograft survival. Cell Mol Immunol 2009; 6: 87-95
70. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, Ten Brinke A: IL- 10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - a comparative study of human clinical- applicable DC. Clin Immunol 2012; 142: 332-342
71. Sela U, Olds P, Park A, Schlesinger SJ, Steinman RM: Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med 2011; 208: 2489-2496
72. Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, et al: Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clin Exp Immunol 2010; 160: 207- 214
73. Popov I, Li M, Zheng X, San H, Zhang X, Ichim TE, et al: Preventing autoimmune arthritis using antigen-specific immature dendritic cells: A novel tolerogenic vaccine. Arthritis Res Ther 2006; 8:R141
74. Hu J, Wan Y: Tolerogenic dendritic cells and their potential applications. Immunology 2011; 132: 307-314
75. Steinman RM, Banchereau J: Taking dendritic cells into medicine. Nature 2007; 449: 419-426
76. van Kooten C, Lombardi G, Gelderman KA, Sagoo P, Buckland M, Lechler R, et al: Dendritic cells as a tool to induce transplantation tolerance: Obstacles and opportunities. Transplantation 2011; 91: 2
77. Steinman RM: Decisions about dendritic cells: Past, present, and future. Annu Rev Immunol 2012; 30: 1-22
78. Randolph GJ, Ochando J, Partida-Sanchez S: Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008; 26: 293-316
79. Lutz MB: Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol 2012; 3: 123
80. Chu CC, Di Meglio P, Nestle FO: Harnessing dendritic cells in inflammatory skin diseases. Semin Immunol 2011; 23: 28-41
81. Hilkens CMU, Isaacs JD: Tolerogenic dendritic cells in clinical practice. Immunity 2010; 13: 15